Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Links AND gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners
Frequently Asked Questions About Link Cell Therapies
What does Link cell therapies do?+
Link Cell Therapies was launched by Stanford founders Robbie Majzner and Crystal Mackall in partnership with investors Samsara BioCapital and Sheatree Capital. The company is developing a best-in-class logic-gate technology to spur a new generation of cell therapies for patients with solid tumors. Links AND gates require two cancer-associated targets for a CAR T cell to attack cancer cells, thereby providing specificity for killing of tumor cells while sparing healthy tissue. Combined with additional technologies under development, Link will advance a suite of exciting internal therapeutic programs while exploring opportunities for value creation with strategic partners
What is Link cell therapies's industry? +
Link cell therapies operates in the Biotechnology research
industry.
What is Link cell therapies's revenue? +
Link cell therapies's revenue is 11m - 100m
What is Link cell therapies's company size? +
Link cell therapies has 11 - 50 employees.
The Go-to Sales Technology According to G2
Get Started With Clodura
Sign Up for Free
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per
month at no cost.
Revenue
Total Funding
Size
